Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B5/00—Measuring for diagnostic purposes; Identification of persons
  • A61B5/15—Devices for taking samples of blood
  • A61B5/150007—Details
  • A61B5/150015—Source of blood
  • A61B5/150022—Source of blood for capillary blood or interstitial fluid
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B5/00—Measuring for diagnostic purposes; Identification of persons
  • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
  • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B5/00—Measuring for diagnostic purposes; Identification of persons
  • A61B5/15—Devices for taking samples of blood
  • A61B5/150007—Details
  • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
  • A61B5/150305—Packages specially adapted for piercing devices or blood sampling devices
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B5/00—Measuring for diagnostic purposes; Identification of persons
  • A61B5/15—Devices for taking samples of blood
  • A61B5/150007—Details
  • A61B5/150358—Strips for collecting blood, e.g. absorbent
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B5/00—Measuring for diagnostic purposes; Identification of persons
  • A61B5/15—Devices for taking samples of blood
  • A61B5/150007—Details
  • A61B5/150801—Means for facilitating use, e.g. by people with impaired vision; means for indicating when used correctly or incorrectly; means for alarming
  • A61B5/150824—Means for facilitating use, e.g. by people with impaired vision; means for indicating when used correctly or incorrectly; means for alarming by visual feedback
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B5/00—Measuring for diagnostic purposes; Identification of persons
  • A61B5/15—Devices for taking samples of blood
  • A61B5/150007—Details
  • A61B5/150847—Communication to or from blood sampling device
  • A61B5/150854—Communication to or from blood sampling device long distance, e.g. between patient's home and doctor's office
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B5/00—Measuring for diagnostic purposes; Identification of persons
  • A61B5/15—Devices for taking samples of blood
  • A61B5/150007—Details
  • A61B5/150847—Communication to or from blood sampling device
  • A61B5/150862—Communication to or from blood sampling device intermediate range, e.g. within room or building
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B5/00—Measuring for diagnostic purposes; Identification of persons
  • A61B5/15—Devices for taking samples of blood
  • A61B5/150007—Details
  • A61B5/150847—Communication to or from blood sampling device
  • A61B5/15087—Communication to or from blood sampling device short range, e.g. between console and disposable
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B5/00—Measuring for diagnostic purposes; Identification of persons
  • A61B5/15—Devices for taking samples of blood
  • A61B5/155—Devices specially adapted for continuous or multiple sampling, e.g. at predetermined intervals
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B5/00—Measuring for diagnostic purposes; Identification of persons
  • A61B5/15—Devices for taking samples of blood
  • A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/483—Physical analysis of biological material
  • G01N33/487—Physical analysis of biological material of liquid biological material
  • G01N33/49—Blood
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
  • G01N33/525—Multi-layer analytical elements
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B5/00—Measuring for diagnostic purposes; Identification of persons
  • A61B5/15—Devices for taking samples of blood
  • A61B5/150007—Details
  • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
  • A61B5/150312—Sterilisation of piercing elements, piercing devices or sampling devices
  • A61B5/150328—Sterilisation of piercing elements, piercing devices or sampling devices by aseptic fluid
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B5/00—Measuring for diagnostic purposes; Identification of persons
  • A61B5/15—Devices for taking samples of blood
  • A61B5/150007—Details
  • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
  • A61B5/150534—Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
  • A61B5/150633—Protective sleeves which are axially extensible, e.g. sleeves connected to, or integrated in, the piercing or driving device; pivotable protective sleeves
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B5/00—Measuring for diagnostic purposes; Identification of persons
  • A61B5/15—Devices for taking samples of blood
  • A61B5/150007—Details
  • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
  • A61B5/150534—Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
  • A61B5/150694—Procedure for removing protection means at the time of piercing
  • A61B5/150717—Procedure for removing protection means at the time of piercing manually removed

Definitions

• This invention relates to devices for testing materials, preferably biological materials, and it relates especially, though not exclusively, to glucose tolerance testing devices, such as (by way of example only) those described in WO-A-2009/024794.
• glucose tolerance testing devices such as (by way of example only) those described in WO-A-2009/024794.
• Such devices test blood samples and enable patients to make at home, or in other convenient locations, tests which would otherwise require their attendance at a clinic or other medical institution, thereby to develop clinical data which can be displayed by the device and/or forwarded elsewhere for expert clinical analysis.
• Devices of the kind described above have particular value to patients lacking ready access to clinical facilities, but the collection of critical evaluation data by patients themselves in domestic or other non-clinical surroundings can compromise the quality of the data.
• test device comprising at least one zone containing biosensor means and/or reagent media and designated to accept a sample of a material, wherein said zone is covered until use by a removable humidity resistant cover.
• a biological test device comprising at least one zone containing biosensor means and/or reagent media and designated to accept a sample of a biological material, wherein said zone is covered until use by a removable humidity resistant cover.
• said device comprises first and second zones each containing respective biosensor means and/or reagent media and designated to accept material samples in a predetermined timing sequence, wherein at least the zone designated to accept the later sample is covered until use by a removable humidity resistant cover.
• respective removable and humidity resistant covers are associated with both of said zones.
• the or each humidity resistant cover comprises a shaped cover made of a plastics material and adapted to be slidably attached to and removed from the device.
• the shaped covers are preferably made by injection moulding.
• the or each cover incorporates a dessicant material.
• the or each cover comprises a peel-off strip of material which is self-adhesively secured to the device so as to temporarily cover its respective zone.
• the or each cover is adherent not only over its respective zone, but also over an adjoining portion of the device so as to cover, until removed, certain procedural instructions relating to the conduct of the test.
• a cover is configured to interact with actuator means associated with electronic components of said device to place the device into an operational, or fully operational, state and/or to cancel an alarm signalling an action point in the test procedure.
• the removal of said cover turns the device on or alters the operational state of the device, for example from a low power- consumption "stand-by" mode to a fully operational mode in which the device consumes more power.
• the time of removal of the cover is recorded by electronic means within the device.
• the device includes electronic means for recording time and for sensing and recording temperature and/or humidity, whereby results that may be compromised due to over-exposure of the device to excessive heat and/or humidity can be identified and assessed accordingly.
• the biological material may be blood, saliva or urine, but the actual materials sensed are not critical to the use of the invention.
• Figure 1 shows a test device in accordance with one example of the invention packaged for storage until use, and with anti-humidity covers provided over sensor zones thereof;
• FIG. 2 shows in more detail the test device of Figure 1 with its anti- humidity covers removed as for use;
• FIG. 3 shows schematically, and by way of example only, a typical operating sequence for devices of the general kind described with reference to Figures 1 and 2.
• a test device 10 in accordance with one example of the invention is packaged for storage within an hermetically sealed pouch 12.
• a dessicant medium may be included in the pouch, either as a separate inclusion or incorporated into the envelope 12.
• the simple, strip-like form of the device 10 is exemplary only; the requirement for the device being that it presents the various essential stages of the test in a logical sequence that can be readily followed by patients without external guidance.
• the device there is provided on the device a series of graphic images which show the actions to be carried out at each stage of the sequence. Written instructions are also provided, but it is intended that the graphics provide easily understood immediate and topical reference data for patient reassurance and guidance.
• the fundamental procedure of the test involves the patient taking a blood sample, for example by way of a finger-prick as is common with routine, day-to-day diabetic testing, both before and after injesting a glycaemic load, typically a glucose drink, thereby to test the patient's tolerance to glucose.
• a glycaemic load typically a glucose drink
• the two blood samples are applied to different sensors in a reasonably strict timing sequence; the sensors developing respective electrical signals that are sent to a data logging area 14 of the device 10, where the signals can be stored as they are, and/or with further processing carried out on them, depending upon the amount of electronic processing incorporated into the device 10.
• the device 10 as a whole, or alternatively just the removable data log 14, can be sent or collected for analysis of the test results recorded therein.
• the results may be displayed on the device 10 in a manner suitable for ready interpretation by or for the person undergoing the test.
• the strip-like device 10 as packaged is, in this example, fitted with two removable covers 16 and 18, each covering a respective one of the two sensors.
• the covers 16 and 18 are injection moulded in plastics material and are configured to be a sliding fit on the strip-like device 10.
• the covers are dimensioned and shaped to fit tightly over the device, but they need not be so configured, as it has been found on testing that even a loosely fitted cover can provide the device 10 with significant protection against exposure to high humidity.
• the strip-like device 10 is made of any convenient self-supporting material, but it is preferably of plastics material since it is relatively easy to produce reliably and repeatedly in volume; however, non-plastic, water-impermeable or water resistant sheet material can be used if preferred.
• the device 10 may bear easily legible images, as the graphics displayed thereon perform, as has been mentioned, an important function in guiding the patient through the procedure.
• the device may be provided with an insert or attachment of material which carries the graphics.
• a first graphic 21 indicates to the patient that the hands should be washed and dried before starting the procedure.
• the patient then actuates a switch device 22 to place the device 10 in a fully operational state.
• the device 10 Prior to the actuation of the switch device 22, the device 10 may be completely switched off, or its circuitry may be switched to a stand-by mode in which it consumes little power.
• the first cover 16 is then removed, revealing graphics 23, 24 designed to guide the patient through the first finger-prick to produce a first blood sample to be dropped on to a receptor 25 which is configured in known manner to convey the blood to a first sensor (not shown); the receptor and its associated sensor constituting a first test zone.
• the cover 16 of course, importantly, covers the receptor 25 until it needs to be exposed to receive the blood sample, thereby protecting the associated sensor against the possible effects of humidity after the device 10 has been removed from the pouch 12. It is preferred, though not necessary, for the cover 16 to cover the graphics 23 and 24 as well as the receptor 25 and its associated sensor, as this expedient reduces the amount of instructional data to which the patient is initially exposed and thus assists the patient to take on board the necessary operations.
• the cover 16 is configured so that its removal either actuates the switch 22, or otherwise automatically places the device 10 in a fully operational state; thereby providing a fail-safe mode of operation, in case the patient should fail to actuate the switch 22.
• the switch device 22 may be a spring-loaded, mechanically operated switch that is normally held open by the presence of the cover 16, but is closed upon withdrawal of the cover 16.
• it may comprise a light-sensitive device and the cover 16, or at least the part thereof that covers the switch device 22 when fitted to the strip-like device 10, may be made of or coloured with an opaque substance such that the switch device 22 is only exposed to light when the cover 16 is withdrawn therefrom.
• the switch device 22 may be of any convenient kind and its interaction with the cover 16 can be achieved in any convenient way.
• the cover 16 need not actuate the switch 22, but may be configured to replicate its effect automatically, by suitable interconnection means communicating directly with the electronics carried by the device 10.
• the patient is then instructed, by way of graphic 26, to injest a prescribed glycaemic load, typically a glucose drink which is provided in a suitable vessel, and then presses a button 27a to start a fixed time period of (in this example) 15 minutes.
• a prescribed glycaemic load typically a glucose drink which is provided in a suitable vessel
• a button 27a to start a fixed time period of (in this example) 15 minutes.
• Other periods can clearly be used if desired or if necessary given differing test conditions and criteria; and in some embodiments the preferred time period is 120 minutes.
• Graphic 28 instructs the patient to relax until the device 10 produces an audio and/or visual warning that the relevant time period has elapsed and it is necessary to complete the test procedure.
• the patient is, in this example though not necessarily, instructed to press a second button 27b which cancels the timer and switches off the warning that indicates the end of the relaxation period.
• the second cover 18 is then removed, exposing graphics 29, 30 and 31 which replicate the graphics 21, 23 and 24 respectively, and which if followed result in the patient applying a second blood sample to a receptor 32, associated with a second sensor, which has remained covered by the cover 18 throughout the procedure to date.
• the cover 18 can be configured so that its removal either actuates the switch 27b, or otherwise automatically cancels the alarm should the patient not already have done so.
• the button 27b is omitted, and its function replicated automatically in response to removal of the cover 18.
• the receptor 32 and its associated sensor constitute a second test zone.
• the results of the test are transferred to electronic storage and/or processing means in the data logging area 14; the successful transfer and thus completion of the test procedure being indicated by the illumination of a lamp device 33, such as an LED. Successful completion of the procedure may also, or instead, be confirmed audibly.
• the data logging area 14 is then preferably detached from the remainder of the device 10 and forwarded to an analysis station such as a clinic or other medical centre.
• the device 10 may be provided with means to calculate the results of the test and to display them, for example on an on-board LCD (not shown), in a readily interpretable manner.
• the data logging section 14 may be fitted with a suitable connector, such as a USB connector, allowing the clinical data resulting from the procedure to be up-loaded via a computer or another suitable electronic device for local display and/or for direct transmission to an analysis centre.
• a suitable connector such as a USB connector
• the switch 22 is intended to be actuated by the patient to place the electronic circuitry in the device 10 into its fully operational state but, if this is not done, the removal of cover 16 automatically achieves the same result as a back-up. In some preferred embodiments of the invention, however, the switch 22 is omitted and the removal of cover 16 is effective to automatically place the device 10 into its fully operational state and in preparation for the addition of the first sample to the receptor 25.
• the electronics within the device 10 include means to record either the time of removal of the covers 16 and 18 or a time-related index permitting the time of removal to be calculated.
• This provides a facility whereby a test relating to a sample applied to the receptor 25 too long after the removal of the cover 16, or to the receptor 32 too long after the removal of the cover 18, can be rejected if it appears that the results may have been compromised.
• the stability of the sensors associated with the receptors 25 and 32 is influenced not only by humidity, but also by other factors such as temperature. It is thus preferred that the device 10 incorporates at least a temperature sensor, and optionally a humidity sensor too. This facility enables the temperature and possibly also humidity to be recorded, for correlation with the times of application of the samples to the receptors 25 and 32; which times are logged automatically, and can be cross- referenced to the times of removal of the covers 16 and 18. On subsequent review of the data recorded by device 10, or of test results derived from such data, the test may be invalidated if it is found that the sensors in the device have been exposed to certain levels of temperature and/or humidity for certain periods of time.
• the covers 16 and 18 may each contain or house a dessicant material, in addition to any dessicant that may be included in the original packaging.
• the arrangement is highly desirable for the arrangement to be such that removal of the covers 16 and 18 from the device 10 actuates a component that logs either the precise times of their removal or a time- related index permitting the time of removal to be calculated.
• the rigid, slide on/slide off, covers 16, 18 may be replaced by peel-off covers which may comprise a plurality of layers, at least one of which may be a dessicant layer.
• the cover 16 associated with the first test zone comprising blood receptor 25 and its associated sensor may be omitted on the expectation that the pouchl2 is not opened until immediately prior to the commencement of the test procedure, and therefore protection from moisture may not be required for the receptor 25 whereas such protection may remain a requirement for the receptor 32.
• the device 10 typically contains an on-board microcontroller (not shown) which is conditioned to receive inputs from the sensors associated with receptors 25 and 32; from the switches such as 22, 27a and 27b and/or means detecting the removal of covers 16 and 18; from environmental sensors such as temperature and/or humidity sensors; and from an RFID transceiver.
• the microcontroller provides outputs operating, among other things, warning or guidance LEDs and sounders used at appropriate times to prompt or warn a user; and also provides outputs when appropriate to the transceiver.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Biomedical Technology (AREA)
• Hematology (AREA)
• Physics & Mathematics (AREA)
• Molecular Biology (AREA)
• General Health & Medical Sciences (AREA)
• Pathology (AREA)
• Biophysics (AREA)
• Animal Behavior & Ethology (AREA)
• Surgery (AREA)
• Public Health (AREA)
• Medical Informatics (AREA)
• Heart & Thoracic Surgery (AREA)
• Veterinary Medicine (AREA)
• Chemical & Material Sciences (AREA)
• Immunology (AREA)
• Urology & Nephrology (AREA)
• Analytical Chemistry (AREA)
• Medicinal Chemistry (AREA)
• Biochemistry (AREA)
• General Physics & Mathematics (AREA)
• Food Science & Technology (AREA)
• Diabetes (AREA)
• Biotechnology (AREA)
• Microbiology (AREA)
• Cell Biology (AREA)
• Ecology (AREA)
• Manufacturing & Machinery (AREA)
• Optics & Photonics (AREA)
• Emergency Medicine (AREA)
• Investigating Or Analysing Biological Materials (AREA)
• Automatic Analysis And Handling Materials Therefor (AREA)

Priority Applications (6)

Applications Claiming Priority (2)

Publications (1)

Family

ID=46003007

Family Applications (1)

Country Status (8)

Families Citing this family (1)

Citations (8)

Family Cites Families (16)

• 2012
  • 2012-03-02 GB GB1203693.5A patent/GB2499838A/en not_active Withdrawn
• 2013
  • 2013-02-26 WO PCT/EP2013/053771 patent/WO2013127762A1/en not_active Ceased
  • 2013-02-26 CN CN201380012093.3A patent/CN104144647B/zh active Active
  • 2013-02-26 EP EP13707343.3A patent/EP2819579B1/en active Active
  • 2013-02-26 ES ES13707343.3T patent/ES2608763T3/es active Active
  • 2013-02-26 JP JP2014559175A patent/JP2015512039A/ja active Pending
  • 2013-02-26 US US14/382,351 patent/US20150037216A1/en not_active Abandoned
• 2014
  • 2014-09-17 IN IN7754DEN2014 patent/IN2014DN07754A/en unknown

Patent Citations (8)

Also Published As

Similar Documents

Legal Events